CCL: Molegro releases Molegro Data Modeller v2.0.0

 Sent to CCL by: "Rene  Thomsen" [rt||molegro.com]
 Aarhus, Denmark, January 19th, 2009 - Molegro is pleased to announce a new
 release of Molegro Data Modeller, a cross-platform application for Data Mining,
 Data Modelling, and Data Visualization.
 Molegro Data Modeller offers a high-quality modelling tool based on
 state-of-the-art data mining techniques combined with a user interface
 experience focusing on usability and productivity. The highly interactive user
 interface of Molegro Data Modeller is ideal for fast and intuitive data
 exploration, as opposed to complex workflow based solutions or command-driven
 statistical products. Molegro Data Modeller is available for Windows, Linux, and
 Mac OS X.
 New features in version 2.0:
  * Classification models: MDM now supports the following multi-class
 classification models: K-Nearest Neighbor and Support Vector Machines with
 Linear, Radial, Sigmoid, and Polynomial kernel functions. The classification
 models support automatic optimization of model parameters and feature selection.
  * Chemistry module: MDM is now able to show 2D depictions of molecules.
 Molecules may be imported in SDF format or as SMILES strings. Molecules may be
 depicted inside the spreadsheet cells or in a separate grid window. It is also
 possible to visualize the molecules directly in the 2D plotter and optionally
 cluster overlapping molecules.
  * A new Bivariate Analysis dialog for analyzing classification results
 (confusion matrix, precision / recall, F-measure, and several other measures).
  * A new threshold-based clustering method.
  * Minor user interface improvements and bug fixes (see Release Notes for
 details).
 To download a trial version, please visit our company website at: http://www.molegro.com.
 For more information contact:
 Rene Thomsen, CEO
 Molegro
 C. F. Moelles Alle, Bldg. 1110
 DK-8000 Aarhus
 Denmark
 E-mail: rt###molegro.com
 Phone: (+45) 89 42 31 65
 About Molegro
 Molegro is a Danish company founded in 2005. Our company concentrates on
 developing high-performance drug discovery solutions leading to a faster
 drug-development process. Our goal is to provide scientifically superior
 products focusing on both state-of-the-art algorithms and an intuitive graphical
 user interface experience.